Sarah Cannon Research Institute (Tennessee) is a clinical research site located in Nashville, Tennessee, United States 37203.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute (Tennessee) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Sponsors: Revolution Medicines, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute (Tennessee) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute (Tennessee) has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.
Sarah Cannon Research Institute (Tennessee) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.